Nouvelle déclaration d'incident
No de la demande: 2025-5601
Numéro de référence du titulaire d'homologation: 2025-US-022420, 022421
Nom du titulaire (nom légal complet, aucune abbréviation): The Hartz Mountain Corporation
Adresse: 200 Plaza Drive, Suite 402
Ville: Secaucus
État: New Jersey
Pays: USA
Code postal /Zip: 07094
Incident chez un animal domestique
Pays: UNITED STATES
État: NEW YORK
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2596-83
Nom du produit: Hartz UltraGuard Flea and Tick Collar for Cats and Kittens - White
Autre (préciser)
CollarOui
Autres unités: Collar
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Cat / Chat
Domestic Mediumhair
1
Homme
14.0
14
lbs
Cutanée
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On approximately 30-Jul-2025, a 14 year old, approximately 14 pound, neutered, male, Domestic Mediumhair cat, in unknown condition, with no known concomitant medical conditions, was administered 1 collar of Hartz UltraGuard Flea and Tick Collar for Cats and Kittens - White (Tetrachlorvinphos (Rabon)) via the topical route around the neck by the animal owner. Approximately 45 minutes after the collar was applied, the cat developed vocalization, disorientation, and weakness. The animal owner removed the collar and bathed the cat's neck using an unknown amount of an unspecified pet shampoo and warm water to try and remove any residue. The clinical signs continued to worsen. Approximately 8 hours after the collar had originally been applied, the cat died at home. A necropsy was not pursued. No further information is expected in this case.
Mort
Assessment: This product contains tetrachlorvinphos, an organophosphate insecticide, that is considered to have a good margin of safety in cats. The active ingredient is poorly absorbed across intact skin. If product residue were ingested only mild GI upset would be expected. Death is not expected and other causes including underlying cardiac disease, metabolic disease, severe flea bite anemia, unknown trauma or toxin exposure should also be considered in this case. Without a necropsy, the cause of death remains unknown and the relationship to product use is inconclusive. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Propriétaire de l'animal
Cat / Chat
Domestic Mediumhair
1
Femme
7.0
7
lbs
Cutanée
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On approximately 30-Jul-2025, a 7 year old, approximately 7 pound, neutered, female, Domestic Mediumhair cat, in unknown condition, with no known concomitant medical conditions, had 1 collar of Hartz UltraGuard Flea and Tick Collar for Cats and Kittens - White (Tetrachlorvinphos (Rabon)) placed around the neck by the animal owner. Approximately 45 minutes post application, the cat developed vocalization, disorientation, and weakness. The animal owner removed the collar and bathed the cat's neck using an unknown amount of an unspecified pet shampoo and warm water to try and remove any residue. The clinical signs continued to worsen. Approximately 8 hours after the collar had originally been applied, the cat died at home. A necropsy was not pursued. No further information is expected in this case.
Mort
Assessment: This product contains tetrachlorvinphos, an organophosphate insecticide, that is considered to have a good margin of safety in cats. The active ingredient is poorly absorbed across intact skin. If product residue were ingested only mild GI upset would be expected. Death is not expected and other causes including underlying cardiac disease, metabolic disease, severe flea bite anemia, unknown trauma or toxin exposure should also be considered in this case. Without a necropsy, the cause of death remains unknown and the relationship to product use is inconclusive. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.